Estadístiques de miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate
Visites totals
views | |
---|---|
miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate | 173 |
Visites totals per mes
views | |
---|---|
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 1 |
February 2025 | 1 |
March 2025 | 0 |
April 2025 | 0 |
Visites al fitxer
views | |
---|---|
Ji_NC_miR.pdf(legacy) | 163 |
Ji_NC_miR.pdf | 31 |
Vistes principals per país
views | |
---|---|
United States | 129 |
Spain | 12 |
Germany | 9 |
France | 7 |
Belgium | 4 |
Czechia | 4 |
Australia | 3 |
China | 2 |
Ireland | 1 |
Saudi Arabia | 1 |
Sweden | 1 |
Visites principals per ciutat
views | |
---|---|
Ashburn | 29 |
Fairfield | 25 |
San Ramon | 22 |
Barcelona | 11 |
Menlo Park | 8 |
Cambridge | 5 |
Mountain View | 3 |
San Diego | 3 |
Seattle | 3 |
Boardman | 2 |
Regensburg | 2 |
Shenzhen | 2 |
Tustin | 2 |
Ann Arbor | 1 |
Cupertino | 1 |
Dallas | 1 |
Dublin | 1 |
Falls Church | 1 |
Oakland | 1 |
Phoenix | 1 |
Redwood City | 1 |
Riyadh | 1 |
Rochester | 1 |
Stockholm | 1 |
Zaragoza | 1 |